MedTrace Logo

International CR Registry

NCT04676100 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 7000

Last updated 2023-12-04

No results posted yet for this study

Summary

The ICRR is a health services registry to establish the quality of CR delivery, and the effectiveness in terms of patient outcomes, in low-resource settings. The purposes of the registry are care optimization, evidentiary support for CR advocacy / policy, and research.

All programs in low-resource settings will be welcome to participate at no cost. Programs will follow procedures approved by their local ethics board for collection of program and patient-reported variables. Assessments occur pre-cardiac rehabilitation (CR), post-CR and annually thereafter.

Conditions

Interventions

OTHER

Cardiac rehabilitation

A CR program is defined as one that offers initial assessment, structured exercise (can be supervised or unsupervised) and at least one other strategy to control risk factors. The registry pertains to phase II CR. Quality of care and patient outcomes are benchmarked with other countries anonymously, through 2 registry dashboards (real-time). The dashboards will also show change over time in 6-month increments; Sites will be encouraged to continue to provide data on new patients until all indicators show quality as possible. Sites will be supported in quality improvement by the ICRR user sub-committee. High-performing programs will be recognized on ICRR's website and ICCPR's social media accounts. This mechanism may be used in future to support program accreditation.

Sponsors & Collaborators

  • International Council of Cardiovascular Prevention and Rehabilitation (ICCPR

    collaborator UNKNOWN

  • York University

    collaborator OTHER

  • Qatar University

    collaborator OTHER

  • University Health Network, Toronto

    lead OTHER

Principal Investigators

  • Sherry L Grace · York University & University Health Network

  • Karam Turk-Adawi, PhD · Qatar University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-27
Primary Completion
2036-06-30
Completion
2041-06-30

Countries

  • Qatar

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04676100 on ClinicalTrials.gov